ANAPA BIOTECH A/S: Financial statements 2019
CVR: 27585167
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ANAPA BIOTECH A/S (CVR 27585167) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 104,000 and a net result of DKK -3,813,000 compared with DKK -693,000 the year before. That is a decrease of 55.9% compared with the year before. Equity in the 2019 report amounted to DKK 0. The company had 1 employee in the financial year.
- Gross Profit
- DKK 104,000
- Profit/Loss
- DKK -3,813,000
- Equity
- DKK 0
- Total Assets
- DKK 1,693,000
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 104K | -3.8M | 0 | 1 |
| 2018 | - | 236K | -693K | 3.8M | 1 |
| 2017 | - | 360K | -5.2M | 4.5M | 1 |
| 2016 | - | -219K | -27M | 9.7M | 1 |
| 2015 | - | -589K | -14.4M | 36.7M | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
ANAPA BIOTECH A/S has published its annual report for 2018. Gross profit came to DKK 236,000, and the net result was DKK -693,000.
About ANAPA BIOTECH A/S
ANAPA BIOTECH A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2004. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named QUANTIBACT A/S and LNA BACTERIAL DETECTION A/S. The management consists of Søren Morgenthaler Echwald. The board consists of Anette Kofod Echwald (chair), Caroline Marie Morgenthaler Echwald and Søren Morgenthaler Echwald. The company is owned by Apana Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 263,027 and a net result of DKK 488,982 compared with DKK 7,646,635 the year before. Equity in the 2025 report amounted to DKK 10,970,173.